Macrocyclics
Macrocyclics 專(zhuān)業(yè)致力于生產(chǎn)用于核醫(yī)學(xué)和醫(yī)學(xué)成像的定制的螯合劑。我們?yōu)榭蛻?hù)定制用于臨床試驗(yàn)并且符合 cGMP(動(dòng)態(tài)藥品生產(chǎn)管理規(guī)范)標(biāo)準(zhǔn)的產(chǎn)品,我們提供生物偶聯(lián)服務(wù)和咨詢(xún)服務(wù)以便幫助客戶(hù)選擇適合其特定需求的同位素。
MACROCYCLICS 簡(jiǎn)介
從1995年開(kāi)始 Macrocyclics 就成為了為醫(yī)學(xué)提供高性能螯合劑技術(shù)的全球***。Macrocyclics 的團(tuán)隊(duì)致力于為客戶(hù)提供發(fā)展成熟和富有**的螯合劑與服務(wù),幫助應(yīng)對(duì)分子成像和核醫(yī)學(xué)方面的挑戰(zhàn)。
AREVA MED 簡(jiǎn)介
AREVA Med 是阿?,m (AREVA) 下屬公司,專(zhuān)門(mén)從事富有**精神的****產(chǎn)品的開(kāi)發(fā)。AREVA Med 為生產(chǎn)高純度鉛-212 (212Pb) 開(kāi)發(fā)了新工藝,這種稀有金屬目前在發(fā)展前景良好的核醫(yī)學(xué)研究領(lǐng)域處于核心地位。2011年,AREVA Med 收購(gòu)了全球高性能螯合劑技術(shù)*** Macrocyclics。AREVA Med 還和美國(guó)國(guó)家癌癥研究所 (NCI)、阿拉巴馬大學(xué)伯明翰分校 (UAB) 及法國(guó)國(guó)家健康與醫(yī)學(xué)研究院 (Inserm) 等***科學(xué)合作伙伴開(kāi)展合作。2012年,AREVA Med 和羅氏 (Roche) 達(dá)成了戰(zhàn)略聯(lián)盟,以便共同創(chuàng)造全新、先進(jìn)的阿爾法放射****技術(shù)來(lái)鎖定和消滅某些侵襲性特別強(qiáng)的癌癥細(xì)胞。
Macrocyclics 產(chǎn)品列表:
Macrocyclics 雙功能配體
p-SCN-Bn-TCMC
p-NO2-Bn-Cyclen
p-NO2-Bn-DOTA
p-NH2-Bn-DOTA
p-NH2-Bn-DOTA-tetra(t-Bu-ester)
p-SCN-Bn-DOTA
DOTA-tris (t-Bu ester)
DOTA-mono-NHS-tris(t-Bu ester)
Maleimido-mono-amide-DOTA-tris (t-Bu ester)
Maleimido-mono-amide-DOTA B-272
Fmoc-L-Lys-mono-amide-DOTA-tris(t-Bu ester)
2-Aminoethyl-mono-amide-DOTA-tris(t-Bu ester)
Azido-mono-amide-DOTA-tris(t-butyl ester)
DOTA-NHS-ester
Azido-mono-amide-DOTA
p-NH2-Bn-DTPA
p-NH2-Bn-DTPA-penta (t-Bu ester)
p-SCN-Bn-DTPA
p-NH2-CHX-A"-DTPA
CHX-A''-DTPA
DTPA-tetra (t-Bu ester)
Maleimido-mono-amide-DTPA
p-NH2-Bn-PCTA
p-SCN-Bn-PCTA
p-NH2-Bn-oxo-DO3A
p-SCN-Bn-oxo-DO3A
p-NH2-Bn-NOTA
p-SCN-Bn-NOTA
Deferoxamine-p-SCN
Deferoxamine-maleimide
DOTA-Biotin-Sarcosine
Samplet Pack- Bifunctionals
Macrocyclics 大環(huán)配體
Cyclam
DO2A
DOTA
DOTP
DOTMA
TETA
DOTAM
DiAmSar
CB-Cyclam
CB-TE2A
NOTA
TACN
Macrocyclics 造影劑
Tm-DOTA
Gd-DOTA
Tm[DOTP]5-
Tm-DOTMA
Eu-DOTA-4AmC
Macrocyclics 中間體
BisCBZ-Cyclen
TrisBOC-Cyclen
DO2A-t-Bu-ester
DO3A-t-Bu-ester
-
Bifunctional Chelators (BFCs)
-
Conjugates
-
Fluorescent Probes
-
Macrocyclic Ligands
-
Magnetic Resonance Reagents
-
Reactive Intermediates
About the company Macrocyclics
Macrocyclics, Inc., a manufacturer of customized chelating agents, is dedicated to leading-edge development of new chelation chemistry platforms critical for advancement of diagnostic and therapeutic medicine.
Macrocyclics offers a large number of services in different areas.
Macrocyclics is operating in a brand new facility equipped with state of the art chemistry and biological laboratories as well as a radio-chemistry lab licensed to include all of the most popular radionuclides for PET imaging and therapeutic applications.
Our new facility was designed to expand our cGMP custom synthesis and bioconjugations services. New and improved capabilities include peptide synthesis, a dedicated radio-isotope hot-lab and two new analytical laboratories with UPLC, QTOF, CE, FTIR, polarimeter.
-
Bioconjugation Services
-
cGMP Services